Blue Crest Capital Management LTD Trevena Inc Transaction History

Blue Crest Capital Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$0.39 - $3.47 $33,916 - $301,768	-86,965 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $125,480 - $203,116	-90,274 Reduced 50.93%	86,965 $184,000
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $255,224 - $397,015	177,239 New	177,239 $255,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.